Dublin, March 18, 2016 -- Research and Markets (http://www.researchandmarkets.com/research/wh78nb/biochips_global) has announced the addition of the "Biochips - Global Strategic Business Report" report to their offering.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020.
This report analyzes the worldwide markets for Biochips in US$ Million by the following Segments: DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Others.
The report further analyzes the market by the following Applications: Research, Diagnostics, and Others.
Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.
The report profiles 79 companies including many key and niche players such as
- Affymetrix, Inc. (US)
- Agilent Technologies, Inc. (US)
- Bio-Rad Laboratories, Inc. (US)
- Cepheid Inc. (US)
- Fluidigm Corporation (US)
- GE Healthcare Ltd. (UK)
- Hoffman-La-Roche Ltd. (Switzerland)
- Illumina, Inc. (US)
- Ocimum Biosolutions Ltd. (India)
- PerkinElmer, Inc. (US)
- Takara Bio, Inc. (Japan)
- Clontech Laboratories, Inc. (US)
- Thermo Fisher Scientific Inc. (US)
Key Topics Covered:
1. INDUSTRY OVERVIEW
2. INNOVATIONS IN THE BIOCHIPS INDUSTRY
3. COMPETITION
4. PRODUCT OVERVIEW
5. BIOCHIP AND MICROARRAY CONSTRUCTION
6. APPLICATIONS OF BIOCHIPS
7. PRODUCT INTRODUCTIONS
8. RECENT INDUSTRY ACTIVITY
9. FOCUS ON SELECT GLOBAL PLAYERS
10. GLOBAL MARKET PERSPECTIVE
Total Companies Profiled: 79 (including Divisions/Subsidiaries 86)
- The United States (45)
- Canada (2)
- Japan (6)
- Europe (22)
- - France (2)
- - Germany (6)
- - The United Kingdom (3)
- - Spain (2)
- - Rest of Europe (9)
- Asia-Pacific (Excluding Japan) (10)
- Middle East (1)
For more information visit http://www.researchandmarkets.com/research/wh78nb/biochips_global
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Biotechnology


TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Washington Post Publisher Will Lewis Steps Down After Layoffs
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 



